Facing a bone marrow transplant diagnosis is one of the most frightening moments a person can experience. When you add a bill of USD 200,000 or more — or a waiting list stretching many months — the fear multiplies. You deserve to know that a genuinely safe, high-quality alternative exists, and that thousands of international patients have taken this path successfully.
Bone Marrow Transplant Cost in India: The Direct Answer
Bone marrow transplant cost in India typically starts from approximately USD 18,000 for an autologous transplant and ranges up to USD 38,000–40,000 for a matched unrelated donor (MUD) allogeneic transplant. That is 70–80% lower than comparable procedures in the United States, United Kingdom, or Australia, yet performed in accredited hospitals with internationally trained haematologists.
The savings are real, not a compromise. India’s lower cost of living, government investment in medical infrastructure, and a deep pool of highly specialised doctors combine to make this possible — not a reduction in clinical standards.
Understanding the Two Main Types of Bone Marrow Transplant
Autologous Transplant (Using Your Own Stem Cells)
In an autologous transplant, stem cells are harvested from your own body before high-dose chemotherapy, then reinfused afterward to rebuild your immune system. It is used for conditions such as multiple myeloma, lymphoma, and certain solid tumours.
Because there is no donor involved, the risk of graft-versus-host disease (GvHD) is eliminated, and the procedure is generally less complex. This is reflected in the lower cost range.
Allogeneic Transplant (Using a Donor’s Stem Cells)
An allogeneic transplant uses stem cells from a matched sibling, a haploidentical (half-matched) family member, or an unrelated matched donor found through a registry. It is the preferred treatment for leukaemia, aplastic anaemia, myelodysplastic syndromes (MDS), and inherited blood disorders.
This procedure is more complex, requires a longer hospital stay, and demands intensive monitoring for GvHD — all of which shape the higher end of the cost range.
2026 Cost Comparison: Bone Marrow Transplant in India vs Other Countries
The table below shows indicative total treatment costs, including hospital stay, procedure, and standard medications (not including flights or accommodation outside the hospital).
| Country | Autologous BMT | Allogeneic BMT (Matched Sibling) | Allogeneic BMT (Unrelated Donor) |
|---|---|---|---|
| India | USD 18,000 – 24,000 | USD 25,000 – 35,000 | USD 32,000 – 40,000 |
| United States | USD 150,000 – 300,000 | USD 200,000 – 350,000 | USD 250,000 – 450,000 |
| United Kingdom | USD 90,000 – 180,000 | USD 120,000 – 220,000 | USD 150,000 – 280,000 |
| Australia | USD 80,000 – 160,000 | USD 110,000 – 200,000 | USD 140,000 – 260,000 |
| UAE | USD 60,000 – 120,000 | USD 80,000 – 150,000 | USD 100,000 – 180,000 |
All figures are indicative 2026 ranges in USD. Final costs vary by hospital, patient condition, length of stay, and complications. Request a written, itemised quote before committing.
For a detailed breakdown of what is typically included — and what may be billed separately — visit our treatments & costs page.
What Drives the Final Price? Key Cost Factors
No two BMT journeys are identical. The following factors will influence where your total bill lands within the ranges above.
- Transplant type: Autologous is less expensive than allogeneic; haploidentical falls in the middle.
- Donor search fees: If an unrelated donor is needed, international registry searches carry additional costs — often USD 3,000–8,000 — before the transplant itself begins.
- Length of stay and isolation: Most BMT patients spend 4–6 weeks as inpatients in a laminar air-flow (sterile isolation) room, which is priced daily.
- Conditioning regimen: The chemotherapy and/or radiation used before transplant varies by protocol and diagnosis.
- Post-transplant medication: Immunosuppressants and antifungal/antiviral prophylactics are required for months. The first 30-day supply is usually bundled; ongoing prescriptions are additional.
- Complications: GvHD, infections, or engraftment failure require additional interventions that increase costs.
- Hospital tier: A JCI-accredited tertiary centre in a major city (Mumbai, Delhi, Chennai, Hyderabad) will charge more than a secondary-tier city hospital. For a procedure this complex, we recommend the top tier.
Is the Quality Comparable?
This is the question that matters most — and the honest answer is yes, for the hospitals we work with.
“India’s top bone marrow transplant centres perform hundreds of procedures a year, maintain dedicated BMT units with positive-pressure laminar air-flow rooms, and publish outcomes data that sits comfortably within international benchmarks. The haematologists and transplant coordinators at these centres trained at leading institutions in the US, UK, and Europe.”
Quality markers to look for when evaluating any centre:
- JCI (Joint Commission International) or NABH accreditation
- A dedicated, purpose-built BMT unit (not a shared oncology ward)
- An in-house apheresis lab for stem cell collection and processing
- 24/7 intensivist cover during the engraftment window
- A haematology team that has performed more than 100 BMTs annually
- Transparent outcome data (overall survival, GvHD rates, engraftment rates)
You can explore more about treatment standards through our organ transplant page, or see the full range of what we coordinate under all treatments.
The Timeline: What to Plan For
A bone marrow transplant is not a procedure you fly in for on a Monday and fly home from on a Friday. Here is a realistic week-by-week guide for an international patient.
Weeks 1–2: Pre-transplant evaluation Blood work, HLA typing confirmation, cardiac and pulmonary clearance, infectious disease screening, and a final treatment-plan meeting with the transplant team.
Weeks 2–4: Conditioning High-dose chemotherapy (and sometimes total body irradiation) to destroy existing marrow and suppress your immune system. You will be admitted to the BMT unit for this phase.
Day 0: Transplant The stem cell infusion itself takes a few hours and feels similar to a blood transfusion. The dramatic work is everything that surrounds it.
Weeks 4–8: Engraftment and monitoring This is the most medically critical window. Your new immune system begins to establish itself. The team monitors daily for engraftment, GvHD, and infection. Most patients remain in the hospital or in closely supervised outpatient housing nearby.
Weeks 8–10: Stable for travel evaluation If engraftment is confirmed, GvHD is controlled, and the infection profile is stable, the team will assess whether you are safe to fly home with a clear follow-up plan.
Plan for a minimum of 8–10 weeks in India, and bring a caregiver. This is a non-negotiable aspect of safety.
Practical Checklist: Before You Travel for a BMT
Use this list to prepare your case file and ensure a smooth pre-approval process.
- Complete medical records from your current oncologist/haematologist (past 12 months)
- Bone marrow biopsy report (pathology and cytogenetics)
- HLA typing results for you and any potential sibling donors
- Recent CBC, metabolic panel, LFT, and KFT results
- Cardiac echo and pulmonary function test results
- List of all current medications and dosages
- Passport valid for at least 12 months beyond your planned return date
- Medical visa application (India’s e-Medical Visa supports multiple entries)
- Travel insurance that explicitly covers pre-existing conditions and medical repatriation
- Caregiver passport and visa (they will stay with you the entire duration)
Our team will help you prepare and organise all of the above. Book a free counselling call to get started — it costs nothing and takes 30 minutes.
Donor Matching for International Patients
If you need an allogeneic transplant and do not have a matched sibling donor, the transplant team in India will coordinate a search through DKMS, the NMDP (Be The Match), or other international registries. This process typically takes 4–8 weeks and runs in parallel with your visa and travel planning so no time is lost.
Haploidentical transplants — using a half-matched family member such as a parent, child, or sibling — are an increasingly viable option and can significantly shorten the search timeline. Indian centres now have strong haploidentical programmes with outcomes approaching matched sibling results.
How IndoMedTour Helps
From the moment you reach out, IndoMedTour provides a free case-review call where a medical coordinator reviews your records and matches you to the right hospital and specialist for your specific diagnosis and transplant type. We obtain written, itemised quotes from multiple accredited centres so you can compare fairly. Our team handles your medical visa application, accommodation near the hospital, and airport transfers. Most importantly, a dedicated patient coordinator stays in contact with you, the hospital team, and your family throughout every phase — from conditioning to discharge and beyond. You bring the worry. We bring the plan.
Start with a free counselling call | Explore organ transplant options | See how the process works